mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |